CERS vs EXPD · rev $201.3M vs P/E 26, rev $10.60B
Cerus Corporation (CERS) versus Expeditors International of Washington, Inc. (EXPD) — a side-by-side from cached financials, not a winner call.
Cerus Corporation (CERS) is a medical devices company listed on US.
Expeditors International of Washington, Inc. (EXPD) is a integrated freight & logistics company listed on NYSE.
Latest reported CERS revenue for 2024-12-31 was $201.3M. Net income was -$21.0M. Revenue was up 7.8% from 2023-12-31 to 2024-12-31. CERS currently screens at market cap $294.4M.
Latest reported EXPD revenue for 2024-12-31 was $10.60B. Net income was $811.6M. Revenue was up 14.0% from 2023-12-31 to 2024-12-31. EXPD currently screens at market cap $21.01B and trailing P/E 26.0.
CERS currently screens at market cap $294.4M. EXPD currently screens at market cap $21.01B and trailing P/E 26.0.
Not investment advice. Open the CERS and EXPD stock pages for the full models.
Not investment advice.